On May 16, 2024, Quinn Fanning, the Chief Financial Officer of Expro Group Holdings NV (NYSE:XPRO), executed a sale of 17,500 shares of the company.
On May 14, 2024, Blake Borgeson, Director at Recursion Pharmaceuticals Inc (NASDAQ:RXRX), executed a sale of 20,054 shares of the company.
On May 15, 2024, Charles Pacala, President and Chief Executive Officer of Ouster Inc (NYSE:OUST), purchased 16,000 shares of the company.